Industry News
All Life Sciences & Technology News
Top stories summarized by our editors
Life SciencesLab Sciences
Top stories summarized by our editors
9/27/2021

Pfizer's Wyeth subsidiary and Merck asked a federal judge to dismiss patent dispute claims concerning their competing vaccines for meningitis and pneumonia. The drugmakers reached a settlement deal that requires Merck to pay royalties and certain milestone fees to Pfizer.

More Summaries:
Wyeth
9/27/2021

Moderna has agreed to supply Peru with 20 million COVID-19 vaccine doses, with deliveries slated to begin by the first quarter of next year. Peru has vaccinated an estimated 37.6% of its population, and Moderna is seeking regulatory approvals for its vaccine before its distribution begins.

Full Story:
Reuters
9/27/2021

A group of leading researchers, veterinarians and farmers have written to the UK's environment secretary George Eustice urging the government to relax current rules on the use of gene editing in the country to develop sturdier farm breeds. Bruce Whitelaw, a professor at the Roslin Institute in Edinburgh, Scotland, said this biotechnology "is particularly important as global warming intensifies and we strive to ensure we are protected against future outbreaks of zoonotic diseases."

Full Story:
The Guardian (London)
More Summaries:
Bruce Whitelaw, Roslin Institute
9/27/2021

Rite Aid and CVS Pharmacy filed a civil antitrust suit against Gilead Sciences, Teva Pharmaceuticals and Bristol-Myers Squibb accusing the drugmakers of paying potential generic drug rivals with cash or services to delay the market entry of generic versions of their blockbuster drugs, including Gilead's hepatitis B drug Vemlidy and HIV treatments Atripla, Descovy, Truvada and Viread. The lawsuit claims Gilead and Bristol use the reverse payment scheme to force insurers and patients to overpay millions for their drugs.

More Summaries:
Teva Pharmaceuticals, Rite Aid
9/27/2021

The Biomedical Advanced Research and Development Authority will give OraSure Technologies up to $13.6 million to help the firm obtain 510(k) clearance for its InteliSwab COVID-19 rapid test. The test is able to deliver results within 30 minutes and has three emergency use authorizations from the FDA for over-the-counter use, point-of-care use and prescription home use.

Full Story:
FDAnews
9/27/2021

The NIH's National Human Genome Research Institute has given a $5 million grant to Geisinger Health System to aid in the development of a point-of-care genetic diagnostic tool that could help identify patients who would benefit from genetic testing for some genetic disorders. Giving physicians real-time access to genetic information could eliminate "the gap between onset of symptoms and genetic diagnosis," said Marc Williams, principal investigator for the project and a professor at Geisinger's Genomic Medicine Institute.

9/27/2021

A 3D-printed microneedle vaccine patch has been developed by scientists from the University of North Carolina at Chapel Hill and Stanford University. The researchers say the patch can prompt an immune response 10 times greater than a vaccine delivered to an arm muscle through a needle.

9/27/2021

The first patient for Neurolief's prospective, multi-center, two-arm clinical study for its Relivion DP has been enrolled. The study aims to evaluate the efficacy and safety of the neuromodulation system as an adjunctive to pharmaceutical management of major depressive disorder.

9/27/2021

Chinese firm Hyper Vision is preparing to launch its Hypervue Headset, an augmented reality headset that could assist surgeons in using medical imaging data during operations. The device could also be used to teach junior surgeons.

9/27/2021

The FDA has given emergency use authorization to Northeastern University's Life Sciences Testing Center for its Life Sciences Testing Center COVID-19 Test. The test uses the Thermo Fisher Scientific TaqPath COVID-19 Combo Kit and runs on Thermo Fisher's Applied Biosystems 7500 Fast Dx system.

More Summaries:
Thermo Fisher